John Cox is a director of Sigilon Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
3/A
Dyne Therapeutics, Inc.
4 Apr 24
4
Dyne Therapeutics, Inc.
27 Mar 24
3
Dyne Therapeutics, Inc.
27 Mar 24
4
Sigilon Therapeutics, Inc.
11 Aug 23
4
Sigilon Therapeutics, Inc.
22 May 23
4
Sigilon Therapeutics, Inc.
27 May 22
4
Sigilon Therapeutics, Inc.
28 Jun 21
4
Sigilon Therapeutics, Inc.
10 Dec 20
3
Sigilon Therapeutics, Inc.
3 Dec 20
4
REPLIGEN CORP
26 Mar 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | DYN Dyne Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 26.06 | 679,853 | 17.72 mm | 679,853 |
11 Aug 23 | SGTX Sigilon Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 341 | 0.00 | 0 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.9984 | 683 | 3.41 k | 0 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.6439 | 683 | 4.54 k | 0 |
19 May 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6366 | 8,888 | 5.66 k | 8,888 |